ZARS PHARMA INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Pharmacokinetic Study of Synera in Healthy Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2012-05-21
Last Posted Date
2012-10-17
Lead Sponsor
ZARS Pharma Inc.
Target Recruit Count
12
Registration Number
NCT01602757
Locations
🇺🇸

Cetero Research, Fargo, North Dakota, United States

Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar Tendinopathy

First Posted Date
2010-04-28
Last Posted Date
2012-03-16
Lead Sponsor
ZARS Pharma Inc.
Target Recruit Count
13
Registration Number
NCT01111773
Locations
🇺🇸

Sports Medicine Clinic, Warren, Michigan, United States

Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points

First Posted Date
2010-04-20
Last Posted Date
2012-03-16
Lead Sponsor
ZARS Pharma Inc.
Target Recruit Count
20
Registration Number
NCT01106989
Locations
🇺🇸

The Center for Clinical Research, Winston-Salem, North Carolina, United States

Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome

First Posted Date
2010-01-25
Last Posted Date
2012-03-16
Lead Sponsor
ZARS Pharma Inc.
Target Recruit Count
20
Registration Number
NCT01055444
Locations
🇺🇸

Injury Care Medical Center, Boise, Idaho, United States

Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome

First Posted Date
2009-10-07
Last Posted Date
2012-03-16
Lead Sponsor
ZARS Pharma Inc.
Target Recruit Count
24
Registration Number
NCT00991068
Locations
🇺🇸

International Clinical Research Institute, Overland Park, Kansas, United States

Evaluate the Depth and Duration of Anesthesia

First Posted Date
2009-05-01
Last Posted Date
2009-05-01
Lead Sponsor
ZARS Pharma Inc.
Target Recruit Count
25
Registration Number
NCT00891163
Locations
🇺🇸

UCSD Medical Center, Thornton Hospital, San Diego, California, United States

Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand Dermatitis

First Posted Date
2009-04-30
Last Posted Date
2012-03-16
Lead Sponsor
ZARS Pharma Inc.
Target Recruit Count
56
Registration Number
NCT00890968
Locations
🇺🇸

Therapeutics Clinical Research, San Diego, California, United States

🇺🇸

DermResearch Inc., Austin, Texas, United States

🇺🇸

Michigan Center for Skin Care Research, Clinton Township, Michigan, United States

Pharmacokinetic Study of Syneraâ„¢ in Neonates and Infants

Phase 4
Suspended
Conditions
First Posted Date
2008-09-05
Last Posted Date
2012-03-23
Lead Sponsor
ZARS Pharma Inc.
Target Recruit Count
11
Registration Number
NCT00747669
Locations
🇺🇸

Children's National Medical Center, Washington, District of Columbia, United States

Lidocaine and Tetracaine Cream to Treat Postherpetic Neuralgia (PHN)

First Posted Date
2008-02-07
Last Posted Date
2012-03-29
Lead Sponsor
ZARS Pharma Inc.
Target Recruit Count
23
Registration Number
NCT00609323
Locations
🇺🇸

ZARS Pharma Clinical Site. Reference: SCP-403, Winston Salem, North Carolina, United States

🇺🇸

ZARS Pharma Clinical Site, San Antonio, Texas, United States

A Phase 3 Study to Evaluate the Long-Term Safety of ThermoProfenâ„¢ in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee.

Phase 3
Terminated
Conditions
First Posted Date
2007-09-19
Last Posted Date
2012-03-16
Lead Sponsor
ZARS Pharma Inc.
Target Recruit Count
179
Registration Number
NCT00532038
© Copyright 2024. All Rights Reserved by MedPath